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Abstract
We have determined the exon-intron organization and the nu-
cleotide sequence of the exons and their flanking intronic DNA
in cloned genomic DNA that encodes the first 526 amino acids
of the al domain of the human red cell spectrin polypeptide
chain. From the gene sequence we designed oligonucleotide
primers to use in the polymerase chain reaction technique to
amplify the appropriate exons in DNA from individuals with
three variants of hereditary elliptocytosis characterized by the
presence of abnormal aI spectrin peptides, 46-50 and 65-68
kD in size, in partial tryptic digests of spectrin. The aI/68-kD
abnormality resulted from a duplication of leucine codon 148 in
exon 4: TTG-CTG to TTG-T1TG-CTG. The aI/50a defect was
associated in different individuals with two separate single
base changes in exon 6: CTG to CCG (leucine to proline) en-
coding residue 254, and TCC to CCC (serine to proline) encod-
ing residue 255. In another individual with the aI/50a polypep-
tide defect, the nucleotide sequence encoding amino acid resi-
dues 221 through 264 was normal. The aI/50b abnormality
resulted from a single base change ofCAG (glutamine) to CCG
(proline) encoding residue 465 in exon 11 in two unrelated
individuals. In a third individual with aI/50b-kD hereditary
elliptocytosis, the entire exon encoding residues 445 through
490 was normal. The relationship of the aI domain polypeptide
structure to these mutations and the organization of the gene is
discussed.
Introduction
The red cell membrane skeleton is composed of the proteins
spectrin, actin, 4.1, and ankyrin, which interact to form an
intricate lattice attached to the inner surface ofthe lipid bilayer
(for reviews see references 1 and 2). This lattice provides the
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mature red cell with structural support and flexibility during
its lifespan. Defects in the various components of the mem-
brane skeleton have been detected in hereditary elliptocytosis
(HE),' hereditary pyropoikilocytosis (HPP), and hereditary
spherocytosis (for reviews see references 1 and 3). HE is a
heterogeneous disorder characterized by variable hemolytic
anemia and elliptical red cell shape. Several abnormalities in
the membrane skeleton have been identified in HE, including
a number that have been localized to spectrin.
Spectrin, the major component of the membrane skeleton,
is composed of dimers of a and ,3 polypeptides, arranged in
antiparallel fashion, that interact to form tetramers and larger
oligomers (1, 2). Normal tetramer and oligomer assembly ap-
pear to be critical to the stability of the membrane skeleton as
well as to normal red cell shape and function (1-3). The region
of the heterodimer formed by interaction between the amino-
terminal end of a spectrin and the carboxy-terminal end of ,
spectrin, referred to as the oligomer binding site, is of func-
tional importance in tetramer and oligomer self-assembly (4).
Analysis of purified normal spectrin by limited digestion
with trypsin and two-dimensional electrophoresis has allowed
the identification of five a and four A spectrin peptide domains
(5). The amino-terminal or aI domain ofa spectrin is observed
as an 80-kD fragment that is usually resistant to further diges-
tion by trypsin in the mild conditions used (5). Using this
method of analysis several abnormalities in the spectrin aI
domain have been detected in individuals with HE. Recently
the amino acid changes in several al domain HE variants have
been identified.
One HE variant, aI/68-kD HE (also referred to as aI/65
HE or Spa1165 HE), has been characterized by a 65-68-kD aI
tryptic fragment (6- 10). Amino acid analysis of spectrin from
two unrelated individuals with this defect revealed a leucine
insertion between residues 148 and 150 that results in an ab-
normal trypsin cleavage after arginine residue 131 (10). Two
forms ofHE have been characterized by the presence of sepa-
rate aI tryptic fragments of 46-50 kD replacing the normal
80-kD al tryptic fragment. One variant, aI/50a-kD HE (or
Spa'11"6 HE; 11- 13), has been found to be associated with two
separate amino acid changes (10). In one individual a proline
was substituted for lysine 254, resulting in trypsin cleavage
after arginine 250; in a second individual serine 255 was re-
placed by proline, resulting in cleavage after lysine 252. A third
form of elliptocytosis, aI/50b-kD HE, has been related to a
substitution of proline for glutamine 465 in one affected indi-
vidual, resulting in an aberrant cleavage by trypsin after argi-
1. Abbreviations used in this paper: HE, hereditary elliptocytosis; HPP,
hereditary pyropoikilocytosis; PCR, polymerase chain reaction.
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nine 462 (10). In the same report, another aI/50b-kD HE
variant was characterized by trypsin cleavage after arginine
464. In this individual, however, an amino acid change was
not identified. Glutamine was present at position 465 and the
following 28 residues were also found to be normal.
We have recently reported the isolation of a 17-kb a spec-
trin clone from a human genomic library (14). Approximately
3 kb of the 3' end of the genomic insert was sequenced and
shown to contain three exons encoding amino acid residues
314 through 444 of the al spectrin polypeptide (14). We have
now mapped and sequenced the remaining exons in this large
clone and two additional 3' exons in an overlapping clone. In
all, 12 exons and their exon-intron boundaries have been se-
quenced, a region encoding the first 526 amino acid residues of
the al domain peptide. Using the a spectrin gene sequence
information we designed three pairs of intronic oligonucleo-
tide primers for use in the polymerase chain reaction (PCR)
technique to amplify the appropriate exons in DNA from indi-
viduals with the aI/68-, aI/50a-, and aI/50b-kD variants of
HE. The nucleotide sequences of the mutant alleles is pre-
sented.
Methods
Genomic cloning and exon mapping. The isolation of clone X3021
from a X Charon 4a library of partially Eco RI-digested human DNA
was previously described (14). The overlapping clone X-aSp-4a was
isolated from a second library of human DNA partially digested with
Hae III and Alu I (15) using a 1.7-kb Eco RI/Hind III fragment corre-
sponding to the 5' end of subclone 3021 El (Fig. 1) as a screening
probe. Identification of exons 8, 9, and 10 on the basis of nucleotide
sequence has been previously described (14). The positions of the
remaining exons were mapped by restriction enzyme digestion of the
cloned genomic DNA, followed by Southern blotting (16) and hybrid-
ization to radiolabeled a spectrin cDNA probes. Most exons could be
accurately mapped using restriction enzyme sites previously identified
in a spectrin cDNA clones. The remaining exons were localized be-
tween infrequent restriction sites present within intronic regions. From
5' to 3' the 1.7-kb Eco RI-Hind III (exons 1 and 2), 2.2-kb Hind
III-Xba I (exons 2 and 3), 4.7-kb Xba I-Xba I (exons 4-6), and the
1.3-kb Xba I-Hind III (exon 7) fragments of 3021 El were subcloned.
The 1.6-(exon I 1) and 0.75-kb (exon 12) Eco RI fragments ofX-aSp-4a
were also subcloned. Exon-containing restriction fragments were fur-
ther digested and subcloned into a double-stranded vector (pGEM;
Promega Biotec, Madison, WI) for sequencing.
The a spectrin cDNA clones used in the exon mapping experi-
ments were isolated from human bone marrow and fetal liver cDNA
libraries. Clones were isolated by antibody screening ofa X gtIl cDNA
expression library (17) with a polyclonal anti-spectrin antibody (18).
Restriction fragments of these cDNAs and of the genomic a spectrin
clone were used as screening probes to isolate additional 5' and 3'
cDNA inserts.
Sequencing ofsubcloned genomicDNA and oligonucleotide synthe-
sis. Subcloned genomic DNA fragments were sequenced using Klenow
(Promega Biotec) or T7 DNA polymerase (Sequenase; United States
Biochemical Corp., Cleveland, OH) and the dideoxy chain termina-
tion method ofSanger et al. (19). For some reactions synthetic oligonu-
cleotides corresponding to cDNA or intronic regions were used as
sequencing primers. Oligonucleotides were synthesized using an auto-
mated synthesizer (Applied Biosystems, Foster City, CA) and purified
by gel electrophoresis or by column chromatography.
Genomic DNA amplification. The relevant a spectrin exons were
amplified by the PCR technique (20, 21) using an automated DNA
thermal cycler (Perkin-Elmer Cetus, Emeryville, CA). Briefly, 1 ,ug of
genomic DNA isolated from peripheral blood leukocytes was added to
a 100-Ml reaction mixture consisting of 50 mM KCI, 10 mM Tris-Cl,
pH 8.3, 1.5 mM MgCl2, 0.01% (wt/vol) gelatin, 0.2 mM each ofdATP,
dCTP, dGTP, and dTTP, and 50 nmol ofeach oligonucleotide primer
(Fig. 2). The reaction mixtures were first heated at 94°C for 5 min to
inactivate any nucleases or proteases that might interfere with the
reaction. After cooling, 2.5 U ofTaq polymerase (Perkin-Elmer Cetus)
were added to each sample. The reaction mixtures were then covered
with mineral oil and amplified for 30 cycles. Each cycle consisted of 1.5
min at 94°C, 2 min at 55°C, and 3 min at 72°C. The last extension
cycle at 72°C was lengthened to 10 min.
Subcloning ofamplified DNA. PCR products were extracted once
with phenol/chloroform, once with chloroform, and precipitated by
ethanol at -20°C. The DNA was pelleted, washed once with 70%
ethanol, dried, and dissolved in 50 ,d of water. The degree of amplifi-
cation was determined by analyzing a portion ofeach PCR product by
agarose gel electrophoresis and ethidium bromide staining. PCR prod-
ucts were blunt end ligated into Hinc II-digested pGEM4 plasmid
DNA (Promega Biotec) using T4 DNA ligase (New England Biolabs,
Beverly, MA) (22).
Direct sequencing ofamplifiedDNA. Total genomic DNA was am-
plified as described above. Amplified DNA products were purified by
agarose gel electrophoresis. The product band was excised and the
DNA concentrated by electroelution and ethanol precipitation. Ap-
proximately one-tenth of the sample was then reamplified using a
sequence renorted bv Sneicher and Mqrthpci t)g% non AgA t%., -u :_ :
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Figure 1. Exon organization of the gene re-
E E E gion encoding the spectrin al peptide do-
|L1 L..4..... 13 main. (A) Two overlapping clones X3021
20 (14), isolated from a library of human ge-
nomic DNA partially digested with Eco
L RI, and X-Sp4a, isolated from a library
made of human genomic DNA partially
digested with Hae III and Alu I (15), are
shown with a composite map ofthe Eco
RI restriction sites (E) and genomic dis-
11 12 tances (in kilobases). (B) 12 exons wereI I mapped by restriction enzyme digestion
490 followed by Southern blotting and hybrid-
/t ization to 32P-labeled cDNA fragment
a /50b probes. Exons and adjacent intron regions
kD HE were subcloned and sequenced (see Fig. 2).The amino acid residues of the al peptide_--2^w .-..- V;-Ij allu ly ana kzJ) e coaiea uy eacn exon are Indicated. Exon I contains an untranslated region (UT) and codingsequence of the first two amino acids of the normal al peptide. The locations of the aI/68-, aI/50a-, and aI/50b-kD HE amino acid substitu-tions (10) are shown.






rate-limiting amount (1 nmol) ofone ofthe amplification primers and
50 nmol of the second primer (23). The amplified DNA was extracted
once with phenol/chloroform and once with chloroform and passed
through a spin column ofSephacryl S-300 (Pharmacia Fine Chemicals,
Piscataway, NJ) in 10 mM Tris-Cl, pH 8.0, and 1 mM EDTA to
remove excess primers. The eluate was concentrated by ethanol precip-
itation, washed with 70% ethanol, and dissolved in 50 ul water. One-
fifth of this sample was sequenced using T7 DNA polymerase and the
rate-limiting PCR primer as the sequencing primer.
Results
Organization and nucleotide sequence ofthe 5' a-spectrin gene
exons. The restriction map presented in Fig. 1 A was derived
from two. large overlapping genomic clones isolated from li-
braries of total human genomic DNA. Clone X302 1, pre-
viously described by Linnenbach et al. (14), was isolated by
hybridization to a synthetic 90-bp double-stranded DNA
probe corresponding to a region of minimum codon degener-
acy in the spectrin al domain. Nucleotide sequence analysis of
the 3' terminal 3 kb identified three exons, numbered 8, 9, and
10 in Fig. 1 B, which encoded amino acid residues 314-444 of
the previously reported a spectrin polypeptide sequence (24,
25). Clone X-aSp-4a was isolated by hybridization to a frag-
ment corresponding to the 5' end ofthe 13 kb Eco RI fragment
(3021 El) of clone X302 1. To map the remaining exons in
3021 El we initially subcloned exon-containing fragments of
intermediate size (see Methods) obtained by digestion with
relatively infrequently cutting restriction enzymes. Exons were
further localized within these subclones after digestion with
more frequently cutting restriction enzymes, Southern blot-
ting, and hybridization to 32P-labeled a spectrin cDNA frag-
ments. The shorter exon-containing fragments mapped in this
manner were subcloned and sequenced.
As shown in Fig. 1 B, we have identified the first 12 coding
exons of the human red cell a spectrin gene. The nucleotide
sequences of all 12 exons and the immediately adjacent intron
sequences are presented in Fig. 2. For completeness we have
included the three exon sequences previously reported in refer-
ence 14. The exon DNA sequence is identical to the sequence
separately determined for a spectrin cDNA encoding the same
region (not shown). The translated amino acid sequence is in
complete agreement with that previously determined by direct
amino acid sequence analysis (24, 25). In all, the 12 exons
encode the first 526 amino acid residues of the al domain of
spectrin. It should be noted that the amino acid sequence pre-
viously reported did not include the amino-terminal Met-Glu-
Gln-Phe-Pro-Lys sequence that is predicted by the gene se-
quence. The use of limited trypsin digestion to generate the
80-kD aI peptide that was sequenced presumably resulted in
the cleavage of the amino terminal 6 amino acids of the a
spectrin chain after the lysine at position 6. The residue num-
bering in Figs. 1 and 2 conforms to the original published
sequence.
The 12 exons varied in size from 43 to 240 bp. Intron size
varied from 0.1 to 2.0 kb.
A compilation ofthe exon-intron junction sequences from
Fig. 2 appears in Table I. The derived consensus 5' donor and
3' acceptor sequences ofAAAG/gtaa and (py), lacag/G are con-
sistent with those reported for other intron-containing eucary-
otic genes (26). All intron sequences immediately adjacent to
exons obey the gt/ag rule (27). In all cases, there was no second
ag dinucleotide pair within the 15 bp upstream of the 3' splice
junction. The 5' donor sequence of exon 5 contains a cryptic
splice sequence within the intron immediately downstream
from the correct splice signal. Use of this alternative splice
sequence, however, would put the coding sequence out of
frame as well as introduce several stop codons in the same
reading frame immediately downstream. Except for exons 6
and 8, all 5' donor sequences end immediately after a triplet
codon. Exons 6 and 8 end after the second base of the coding
triplet, the third base of the codon being located at the start of
the following exon. The same phenomenon occurs in a num-
ber of different eucaryotic genes.
Spectrin gene mutations in aI HE. Several defects in the aI
domain of spectrin have been identified in individuals with
HE (6-13). In aI/68-, al/50a-, and aI/50b-kD HE, amino acid
changes presumably responsible for the abnormalities have
been reported (10). Determination of the exon organization
and sequences encoding the al domain of the protein has al-
lowed us to undertake a study of the DNA sequence of the
genes encoding these three HE variants.
In two unrelated individuals with the aI/68-kD HE defect,
amino acid sequence analysis of the NH2-terminal end of the
abnormal 68-kD tryptic peptide revealed a leucine insertion
between residues 148 and 150 (10). We amplified total geno-
mic DNA from one of these individuals (H.P.) using the
primers for exon 4 indicated in Fig. 2. The resulting 242-bp
double-stranded product was cloned into the Hinc II site of
pGEM4 and sequenced. Ofthe five subclones sequenced, three
contained the normal sequence. Two subclones had a duplica-
tion of leucine codon 148: TTG-CTG to TTG-TTG-CTG.
This result is shown in Fig. 3. Both strands of one mutant
subclone were sequenced and found to agree completely with
the entire normal exon sequence except for the TTG leucine
codon duplication.
The aI/50a-kD HE abnormality has been shown to be as-
sociated with separate proline substitutions involving either
serine 255 or leucine 254 (10). These changes map to exon 6
(Figs. 1 B and 2). Using oligonucleotide primers P16 and P6
indicated in Fig. 2 we amplified total genomic DNA from one
of these individuals (T.S.). DNA sequence analysis of the sub-
cloned normal and mutant exons is shown in Fig. 4 A. A single
base change of CTG to CCG in exon 6 in one allele causes a
substitution of proline for leucine 254.
The mutation of another individual (A.R.) with the aI/50a
peptide abnormality was also studied. Using oligonucleotide
primers P5 and P6, we amplified total genomic DNA. The
PCR product was gel purified and reamplified using a rate-lim-
iting amount of the 3' primer (oligonucleotide P6). The total
asymmetrically amplified DNA product was then directly se-
quenced using primer P6 and T7 DNA polymerase (Sequen-
ase). This procedure results in the simultaneous sequencing of
the amplified exon 6 from both normal and mutant alleles. As
shown in Fig. 4 B, this procedure detected a single base change
of TCC to CCC in codon 255 of one allele resulting in the
substitution of proline for serine. This initial analysis used a 5'
primer (P5) located within the exon sequence, and, as a result,
did not allow a sequence analysis of the complete exon. We
subsequently confirmed the presence of a single base change in
the exon ofthe mutant allele by using primers P16 and P6, and
sequencing after subcloning (not shown).
Genomic DNA from another individual (M.A. in reference
1 1) with HPP and an associated aI/50a-kD defect was also



















































Figure 2. Nucleotide se-
quence of a spectrin gene
exons and adjacent intron re-
gions. Exon sequences are in-
dicated in capital letters, in-
tron sequences in lowercase
letters. The numbering of the
amino acid residues con-
forms to that reported for the
aI spectrin peptide (24, 25).
The locations of the leucine
insertion (A) and the abnor-
mal trypsin cleavage site (#)
in aI/68-kD HE (exon 4),
and the proline substitutions
(t) and abnormal trypsin
cleavage sites (#) in aI/50a-
(exon 6) and aI/50b-(exon
11) kD HE are shown. The
nucleotide sequences of
exons 8, 9, and 10 were pre-
viously reported (14). The
DNA sequences used as oli-
gonucleotide primers in PCR
experiments are underlined.
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studied. Although the precise site of abnormal cleavage by
trypsin in a spectrin from MA has not been identified, the
abnormal alI/50-kD tryptic peptide produced appeared to be
identical in mobility, after two-dimensional electrophoresis, to
that derived from a spectrin of T.S. for which actual amino
acid sequence was obtained. Genomic DNA from MA was
amplified using oligonucleotide primers P5 and P6 and di-
rectly sequenced as described above. In addition, 18 individual
subclones of the PCR product using oligonucleotide primers
P16 and P6 were sequenced. No abnormalities were detected
in the DNA sequence of exon 6 which encodes residues 221
through 264 (i.e., 29 residues upstream and 14 residues down-
stream from the abnormal trypsin cleavage site identified
in T.S.).
A third abnormality of the al domain has been described
in individuals with HE (10). This variant, referred to as
alI/50b-kD HE, is characterized by a 50-kD aI tryptic peptide
and two smaller fragments of 17 and 19 kD not observed in the
aI/50a-kD HE defect. Sequence analysis of the amino-termi-
nal ends of the 17- and 19-kD tryptic fragments from one
individual (H.B.) revealed a substitution of proline for gluta-
mine at position 465 (10). This change maps to a spectrin exon
11 (Figs. 1 B and 2). We amplified total genomic DNA from
HB and a second unrelated affected individual using the
primers indicated. The DNA products were subcloned into
pGEM and sequenced (Fig. 5). In both individuals we detected
a single base change of CAG (glutamine) to CCG (proline) in
codon 465 of exon 11 in one allele.
Spectrin from a third aI/50b-kD HE individual was pre-
viously studied (D.F. in reference 10). An amino acid change
responsible for the abnormal tryptic peptides was not identi-
fied although limited tryptic digestion of a spectrin produced
peptides similar to those of HB. Sequence analysis of the
amino-terminal ends of the 19 and 17 kD peptides identified
the cleavage site as arginine 464, instead of arginine 462 as in
H.B., but revealed no amino acid changes in the following 28
residues. Genomic DNA from DF was amplified and sub-
cloned, and the entire exon 11 was sequenced as described
above. A total of 20 separate subclones were sequenced. A
single subclone had an AAC (asparagine) to GAC (aspartate)
change at position 450. In 19 additional subclones sequenced,
however, this base change was not detected and the DNA se-
quences were completely normal. The base change noted in
the single subclone was most likely due to an error introduced
during amplification by the Taq polymerase. We have con-
cluded that the entire exon 1 1, encoding 19 amino acid resi-
dues upstream and 26 amino acid residues downstream from
the abnormal trypsin cleavage site after arginine 464, is normal
in both alleles of D.F.
Discussion
Molecular cloning of the gene region encoding the NH2 ter-
minus of human erythroid a spectrin is of interest for several
MUTANT





NORMAI:.. Figure 3. Nucleotide se-quence of the aI/68-kDHE gene mutation. Ge-nomic DNA from pe-ripheral blood leuko-cytes of heterozygouspatient H.P. was ampli-fied using Taq polymer-ase and the oligonucleo-
tide primers for exon 4
indicated in Fig. 2. The
product DNA was sub-
cloned and sequenced.
The relevant regions of
exon 4 of the normal al-
lele (TTG-CTG) and the mutant allele (TTG-TTG-CTG) containing
the duplicated leucine codon 148 are shown.
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Table I. Nucleotide Sequences ofa Spectrin Exon Donor/Acceptor Splice Sites
































reasons. First, a number ofdefects involving the NH2-terminal
or al domain of spectrin have been detected in HE and HPP.
Knowledge of the exon sequences and exon-intron organiza-
tion of the region encoding the al domain of spectrin will
facilitate the study of these mutations. Second, an under-
standing of the organization of the erythroid a spectrin gene
may provide significant insight into the molecular evolution of
the spectrin gene and other members of the gene family to
which it belongs. Finally, although not the subject of this re-
port, the identification of the a spectrin promoter would allow
studies on the mechanism of tissue-specific expression of the a
spectrin and other genes expressed exclusively during ery-
throid cell differentiation.
We have reported here the DNA sequences and the organi-
zation of the first 12 coding exons of the human erythroid a
spectrin gene. The coding region studied spans - 17 kb and
encodes the first 526 amino acid residues of the aI domain.
Given a total estimated length of -2,400 amino acids for a
spectrin, the entire gene is predicted to be composed of - 55
exons and to be - 80 kb in size, assuming a similar frequency
and length of introns in the remainder of the gene.
The a spectrin polypeptide has been previously shown to
be a long rod-shaped molecule composed of - 20 homologous
A
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Figure 4. Nucleotide sequence of two separate aI/50a-kD HE gene
mutations. (A) Genomic DNA from T.S., heterozygous for an
aI/50a-kD protein defect, was amplified using Taq polymerase and
the oligonucleotide primers P16 and P6 for exon 6. The product
DNA was subcloned and sequenced. The CTG encoding leucine 254
in the normal allele is changed to CCG encoding proline in the mu-
tant allele. (B) Genomic DNA from a second heterozygous individ-
ual (A.R.) was amplified using oligonucleotide primers P5 and P6.
The product DNA was gel purified, reamplified assymetrically using
a rate-limiting amount of primer P6, and sequenced directly. The se-
quence reveals the TCC serine codon 255 of the normal allele and a
single base change to CCC encoding proline in the exon of the mu-
tant allele.




















106 amino acid repeats, each of which can be f
triple helical structure connected to adjacent repe;
nonhelical connecting region (25). The high degr
ogy between the individual repeat units, as well a
vation of a triple helical conformation in each rep
suggest that the gene evolved by repeated duplicat
a smaller DNA domain. In the region of the gene
studied, however, there is no obvious relationship
exon-intron organization of the gene and the rep
of the polypeptide. Exon size varied from 43 to 2
intron size varied from 0.1 to 2.0 kb. As shown iI
repeat unit of the al domain is interrupted by
exon-intron junctions. Furthermore, no single ex
ing ofadjacent exons encodes a distinct 106 amin
unit and none of the splice junctions defines 1
repeat. This is different from the situation in the gi
dystrophin, the protein that is defective in Ducher
dystrophy and a member ofthe extended family o
proteins. In dystrophin, which is composed larg
units of 109 amino acid residues similar to thos4
the ends of the first six protein repeats appear t
exactly by exon-intron boundaries (28). A more
derstanding of the molecular evolution of the a
must await exon-intron mapping of the entire ge
It is apparent in Fig. 6, however, that the aI/
and aI/50b-kD HE mutations studied here are 1








Figure 6. Relationship of a spectrin polypeptide repeal
exon-intron organization and HE mutations. The first
amino acid repeat units (1-5) and the amino-terminal
viously described (25) are shown with the approximate
the exon-intron junctions (v), amino acid changes (*),
trypsin cleavage sites (#) in aI/68-(repeat 2), aI/50a-(re
al/50b-(repeat 5) kD HE. The amino acid changes anc
trypsin cleavage site in aI/78-kD HE (29, 30) are also i
and 1'). The approximate regions in each repeat segme
helix 1, 2, and 3, and the connecting region (c.r.) are a]
Nucleotide se- proximately the same position (residues 25, 26, or 27) in the
fthe aI/50b- 106 amino acid lengths of repeats 2, 3, and 5 of a spectrin.
iutation. Ge- Each of these mutations occurs at the junction between the
NA from a COOH-terminal end of helix 3 and the region postulated to
Yous individual connect adjacent triple helical structures referred to as the
5S amplified connecting region in the model of spectrin folding proposed by
q polymeraoe Speicher and Marchesi (25). These amino acid changes may
)orgonucleotide exert their effect by altering critical relationships within the a
nFig. 2. The spectrin polypeptide or by disturbing interchain relationships
duct was sub- between the antiparallel a and ,B spectrin polypeptides. The
id sequenced. end result is probably a functionally significant change in con-
formation of the important head-end or oligomer binding site
of the spectrin heterodimer resulting in impaired spectrin
dimer self-association. Two additional amino acid substitu-
folded into a tions have recently been described in HE variants associated
ats by a short with an aI/78-kD tryptic fragment (29, 30). Interestingly, the
ee of homol- protein defects in these cases are located in approximately the
is the conser- same position (residues 18 and 22) of repeat 1 of a spectrin.
)eat segment, The present experiments confirm the nature of the pre-
Lion events of viously described amino acid changes associated with aI/50a-
that we have and aI/50b-kD HE by demonstrating the specific single base
between the substitutions in the a spectrin gene of affected individuals.
)eat structure Both of these anomalies are heterogeneous at the molecular
240 bp, while level. Two separate nucleotide changes resulting in two differ-
n Fig. 6, each ent amino acid replacements were observed in aI/50a-kD HE.
one or more A third aI/50a defect in M.A., not yet specifically character-
Lon or group- ized, is different from these two. At least two different defects
ko acid repeat are associated with aI/50b-kD HE: a single nucleotide change
the end of a resulting in a proline substitution for glutamine 465 detected
ene encoding in two unrelated individuals, and an as yet unidentified but
mne muscular different mutation in individual D.F.
ofspectrinlike In contrast, aI/68-kD HE appears to be the result of a
rely of repeat single gene mutation. The same TTG codon duplication has
e in spectrin, been observed in nine individuals from five separate families
to be defined from North America and France (31) and in five unrelated
complete un- individuals from North Africa (32). The occurrence of the
spectrin gene same mutation in all individuals studied is unlikely to be the
ne. result of multiple separate identical mutation events. Instead,
/68-, aI/50a-, it probably reflects a founder effect. The relatively high inci-
ocated at ap- dence of aI/68-kD HE in Central West Africa (33) suggests
that the original mutation spread from this region to Northern
Africa and, subsequently, to North America and Europe. It is
tempting to speculate that the relatively high frequency of this
ix 2 turn HE defect in black individuals reflects some type of beneficial
effect in the heterozygous state, similar to the situation in the
sickle cell trait where individuals are protected against malaria
-v------# infections. As yet, however, no direct evidence for this possibil-
ity exists.
v The duplication of leucine codon 148 in aI/68-kD HE is
v probably the result of the process called frameshift mutagen-
esis (34), in which there is an intrachromosomal mispairing of
sister chromatids during meiosis in regions of short directly
repeated sequences. Such direct repeats, as small as two nu-
units to cleotides, have been shown to be associated with both dele-
five 106 tions and insertions in the human globin genes (35-37).
end (1') pre- Most known amino acid changes causing the various types
locations of of HE occur close to the site of abnormal tryptic cleavage of
peat 3), and the al domain. The mutations thus far identified that are lo-
1 the abnormal cated the furthest away from the abnormal tryptic cleavage site
indicated (in 1 occur in aI/78-kD HE where the amino acid replacements are
nt comprising at residue 35 or 39 and the abnormal cleavage at residue 10;
iso indicated. i.e., 25 and 29 residues proximal to the mutation (29, 30). In
1250 Sahr et al.










two individuals studied, one with aI/50a-kD HE and one with
aI/50b-kD HE, a gene mutation was not identified in the exon
encoding the site of the abnormal tryptic cleavage. In the case
of the aI/50a variant this exon encodes 29 and 14 amino acid
residues to either side ofthe cleavage site. In the aI/SOb variant
the exon encodes 19 and 28 amino acid residues to either side
of the cleavage site. Thus, the protein defects in these two
individuals may be located more distally (or proximally) to the
abnormal tryptic cleavage site in neighboring exons of the a
spectrin gene. Or, as recently suggested in the case of one
aI/74-kD HE variant (38), the aberrant al tryptic cleavage
may not be the result of a mutation in the a spectrin chain,
but, rather, a mutation in the apposing , spectrin chain.
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